Atlas Trials

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Clinical trial NCT02194231 · COMPLETED

Trial details

NCT number
NCT02194231
Sponsor
Mario Negri Institute for Pharmacological Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2013-07-01
Primary completion
2019-12-12
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.